Vimarsana
Biggest News Aggregation in the World

Page 5 - Private Financing News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Private Financing. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Private Financing Today - Breaking & Trending Today

Georgia Bio Awards 2021 Golden Helix to VERO Biotech for Best Deal of the Year - Vimarsana News

Georgia Bio Awards 2021 Golden Helix to VERO Biotech for Best Deal of the Year

Georgia Bio Awards 2021 Golden Helix to VERO Biotech for Best Deal of the Year PR Newswire VERO Biotech LLC, an Atlanta, Georgia-based biotechnology company focused on saving lives, alleviating suffering, and improving the health economics of care, today announced that the company was awarded the coveted Golden Helix "Best Deal of the Year" Award for 2021 by Georgia Bio, the state's life science trade association. VERO Biotech was recognized in the category of Private Financing, in a virtual awards ceremony last night. Georgia Bio Awards 2021 Golden Helix to VERO Biotech for Best Deal of ...

A Liberian Scholar Graduates With Two Distinct Masters from University of Kigali and Mount Kenya University - Vimarsana News

A Liberian Scholar Graduates With Two Distinct Masters from University of Kigali and Mount Kenya University

A Liberian Scholar Graduates With Two Distinct Masters from University of Kigali and Mount Kenya University A Liberian Scholar Graduates With Two Distinct Masters from University of Kigali and Mount Kenya University Share A Kigali-based Liberian scholar, Amara M. Kamara, recently graduated with two masters, an MSc in Project Management from the University of Kigali and an MA in Development Studies from Mount Kenya University, Kenya.  Amara, famous as the Kigali trained, ably represented Liberia during his studies in Kigali and left an indelible impression on his professors, fellow students, ...

Regulus Therapeutics Reports Fourth Quarter and Year-End 2020 Financial Results and Recent Updates - Vimarsana News

Regulus Therapeutics Reports Fourth Quarter and Year-End 2020 Financial Results and Recent Updates

Share this article LA JOLLA, Calif., March 9, 2021 /PRNewswire/ --  Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs (the "Company" or "Regulus"), today reported financial results for the fourth quarter and year ended December 31, 2020 and provided a corporate update.  "Regulus finished the year on a high note", stated Jay Hagan, CEO of Regulus. "We advanced RGLS4326 into a Phase 1b study in ADPKD patients, achieved an enrollment milestone for RG-012 with Sanofi and its Phase 2 clinic...

Eve & Co Announces CAD$1M Private Financing - Vimarsana News

Eve & Co Announces CAD$1M Private Financing

Eve & Co Announces CAD$1M Private Financing December 30, 2020 17:36 ET | Source: Eve & Co Incorporated Eve & Co Incorporated Strathroy, Ontario, CANADA STRATHROY, Ontario, Dec. 30, 2020 (GLOBE NEWSWIRE) -- Eve & Co. Incorporated (TSXV: EVE) (OTCQX: EEVVF) (the “Company” or “Eve & Co”) announces that its wholly-owned subsidiary Natural MedCo Ltd (“NMC”) has entered into a CAD$1M financing loan with a private consortium of lenders (the “CAD$1M financing” or the “Loan”). The CAD$1M financing has a two-year term and is to be receiv...

Long Beach Aerial Tram Group Ready To Start Study - Vimarsana News

Long Beach Aerial Tram Group Ready To Start Study

A proposal to build an aerial tram system in downtown Long Beach will likely move forward early next year, as the developers behind the idea say they have secured private funding to conduct an initial study. Clay Sandidge, a co-developer for the project, which has been dubbed “The Wave,” said in a phone interview this week that his team expects to begin a feasibility study and cost-benefit analysis by the end of March. The study will cost an estimated $500,000 and likely take 60-to-90 days to complete, Sandidge said, but “no more than six months.” Sandidge and his team hav...